USA - NYSE:BMA - US05961W1053 - ADR
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.02T | 4.76T | 2.91T | 512.02B | 390.19B | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | 2.46T | 1.62T | 829.35B | 305.33B | 255.25B | |||
| Non Interest Income | 1.56T | 3.14T | 2.08T | 206.70B | 134.93B | |||
| Loan Loss Provision | 234.82B | 109.35B | 45.94B | 6.56B | 4.78B | |||
| Net Interest Income after Provision | 2.22T | 1.51T | 783.40B | 298.77B | 250.47B | |||
| Non Interest Expense | -3.17T | -4.31T | -2.00T | -442.97B | -329.33B | |||
| Minority Interest Expense | -1.96B | -989.13M | -350.74M | -7.08M | -1.46M | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | null | null | null | null | null | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | null | null | null | null | null | |||
| Operating Income | null | null | null | null | null | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 612.41B | 336.77B | 862.04B | 62.50B | 56.07B | |||
| Income Tax | 196.43B | 32.76B | 282.43B | 19.45B | 3.24B | |||
| Net Income | 414.02B | 303.03B | 579.26B | 43.04B | 52.83B | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 6.59K | 4.82K | 9.22K | 685.1323252676789 | 841.0478869205862 | |||
| Non GAAP EPS | 6.59K | 4.17K | 8.15K | null | 418.5634968384757 | |||
| Statistics | ||||||||
| Profit Margin | 10.31% | 6.37% | 19.92% | 8.41% | 13.54% | |||
All data in ARS